Khun

Nobody is paying enough attention to what is happening at Figure AI right now. Its humanoid robots are now working 70 hours straight livestream, sorting packages at around 2.6 seconds each. That is reportedly FASTER than the average human worker (3secs). They have now sorted over 88,000 packages with no human assistance, no teleoperation, and no cloud. The company says it will NOT STOP the stream until a robot physically breaks. The labor market is about to be redefined.

There's a great asymmetric setup with $IBRX if you look it purely from a short/medium-term investing. High upside and Limited downside The upside: it becomes incredible effective against cancer and becomes a standard care in oncology treatment. The downside: the regulatory hurdles, pushback from incumbents. It is also important to note that the founder is a missionary-type founder who is already rich. It shields against the typical funding and volatility that a biotech would face. Recent advancements in regulatory front (Saudi approval) and operational front (100m+ revenue, growing) greatly de-risk the company. For this reason, I have made it one of my largest holding. Will study more on the technicality of its solutions and share more. It's good to be a part of a mission for greater good and make money as well. Let's go!